HK20588A - Crystalline benzenesulfonate salts of sultamicillin - Google Patents

Crystalline benzenesulfonate salts of sultamicillin Download PDF

Info

Publication number
HK20588A
HK20588A HK205/88A HK20588A HK20588A HK 20588 A HK20588 A HK 20588A HK 205/88 A HK205/88 A HK 205/88A HK 20588 A HK20588 A HK 20588A HK 20588 A HK20588 A HK 20588A
Authority
HK
Hong Kong
Prior art keywords
sultamicillin
crystalline
salts
salt
formula
Prior art date
Application number
HK205/88A
Other languages
German (de)
English (en)
French (fr)
Inventor
Wayne Ernest Barth
Vytautas John Jasys
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of HK20588A publication Critical patent/HK20588A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/28Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with modified 2-carboxyl group
    • C07D499/32Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK205/88A 1982-04-23 1988-03-17 Crystalline benzenesulfonate salts of sultamicillin HK20588A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/371,156 US4432987A (en) 1982-04-23 1982-04-23 Crystalline benzenesulfonate salts of sultamicillin

Publications (1)

Publication Number Publication Date
HK20588A true HK20588A (en) 1988-03-25

Family

ID=23462725

Family Applications (1)

Application Number Title Priority Date Filing Date
HK205/88A HK20588A (en) 1982-04-23 1988-03-17 Crystalline benzenesulfonate salts of sultamicillin

Country Status (27)

Country Link
US (1) US4432987A (cg-RX-API-DMAC7.html)
EP (1) EP0092968B1 (cg-RX-API-DMAC7.html)
JP (1) JPS58201792A (cg-RX-API-DMAC7.html)
KR (1) KR860001279B1 (cg-RX-API-DMAC7.html)
AU (1) AU536854B2 (cg-RX-API-DMAC7.html)
CA (1) CA1187484A (cg-RX-API-DMAC7.html)
CS (1) CS235320B2 (cg-RX-API-DMAC7.html)
DD (1) DD209632A5 (cg-RX-API-DMAC7.html)
DE (1) DE3362502D1 (cg-RX-API-DMAC7.html)
DK (1) DK162168C (cg-RX-API-DMAC7.html)
EG (1) EG16412A (cg-RX-API-DMAC7.html)
ES (1) ES521728A0 (cg-RX-API-DMAC7.html)
FI (1) FI76092C (cg-RX-API-DMAC7.html)
GR (1) GR78582B (cg-RX-API-DMAC7.html)
HK (1) HK20588A (cg-RX-API-DMAC7.html)
HU (1) HU187068B (cg-RX-API-DMAC7.html)
IE (1) IE54628B1 (cg-RX-API-DMAC7.html)
IL (1) IL68453A (cg-RX-API-DMAC7.html)
NO (1) NO156202C (cg-RX-API-DMAC7.html)
NZ (1) NZ203988A (cg-RX-API-DMAC7.html)
PH (1) PH18035A (cg-RX-API-DMAC7.html)
PL (1) PL134978B1 (cg-RX-API-DMAC7.html)
PT (1) PT76587B (cg-RX-API-DMAC7.html)
SG (1) SG104087G (cg-RX-API-DMAC7.html)
SU (1) SU1138030A3 (cg-RX-API-DMAC7.html)
YU (1) YU43170B (cg-RX-API-DMAC7.html)
ZA (1) ZA832845B (cg-RX-API-DMAC7.html)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336762A (en) * 1985-11-18 1994-08-09 Access Pharmaceuticals, Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
EP0247156B1 (en) * 1985-11-18 1993-06-23 Access Pharmaceuticals Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
KR910009271B1 (ko) * 1989-06-20 1991-11-08 김영설 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염
KR100314558B1 (ko) * 1994-05-02 2002-02-28 시오노 호히코 피롤리딜티오카르바페넴유도체의결정과,상기결정을함유한동결건조제제및그제조방법
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
BR0313831A (pt) 2002-08-29 2005-07-05 Taisho Pharmaceutical Co Ltd Sais benzenossulfonato de derivados de 4-flúor-2-cianopirrolidina
BRPI0408716B1 (pt) * 2003-03-27 2017-08-29 Basilea Pharmaceutica Ag. Cefalosporin in crystalline form, process for its preparation and its uses, and preparation of cephalosporin
KR20060108692A (ko) * 2003-10-31 2006-10-18 알자 코포레이션 메트포르민의 개선된 흡수를 위한 조성물 및 제형
FR2877696B1 (fr) 2004-11-09 2009-09-18 Renault Sas Dispositif et procede d'estimation en temps reel de l'angle de debut de combustion d'un moteur a combustion interne
EP2253615B1 (en) 2007-08-22 2014-07-09 AstraZeneca AB Cyclopropyl amide derivatives
PE20121470A1 (es) 2007-10-26 2012-11-18 Univ California Compuestos de diarilhidantoina como antagonistas del receptor de androgeno
EA018907B1 (ru) * 2009-01-30 2013-11-29 ГЛЭКСОСМИТКЛАЙН ЭлЭлСи Кристаллический гидрохлорид n-{(1s)-2-амино-1-[(3-фторфенил)метил]этил}-5-хлор-4-(4-хлор-1-метил-1h-пиразол-5-ил)-2-тиофенкарбоксамида
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
JP2012532886A (ja) * 2009-07-10 2012-12-20 エボルバ アクチェンゲゼルシャフト ジイン組成物
JP5746718B2 (ja) * 2010-02-18 2015-07-08 アストラゼネカ・アクチエボラーグAstrazeneca Aktiebolag シクロプロピルアミド誘導体からなる固体形態
US20110201623A1 (en) * 2010-02-18 2011-08-18 Uczynski Michael A Crystalline Form Of A Cyclopropyl Benzamide Derivative
CN104903289B (zh) * 2012-12-03 2017-06-09 株式会社钟化 还元型辅酶q10衍生物及其制造方法
WO2015034031A1 (ja) * 2013-09-05 2015-03-12 田辺三菱製薬株式会社 新規な結晶性アリールアルキルアミン化合物およびその製造方法
HRP20201343T1 (hr) * 2014-10-21 2020-11-27 Ariad Pharmaceuticals, Inc. Kristalni oblici 5-kloro-n4-[-2-(dimetilfosforil)fenil]-n2-{2-metoksi-4-[4-(4-metilpiperazin-1-il)piperidin-1-il]pirimidin-2,4-diamina
CN104958318A (zh) * 2015-08-04 2015-10-07 青岛蓝盛洋医药生物科技有限责任公司 一种治疗感染性疾病的药物舒巴坦钠组合物
LT3390358T (lt) * 2016-01-22 2020-11-25 Sandoz Ag Kristalinis eravaciklino bis-hidrochloridas
IL263996B2 (en) 2016-07-07 2024-03-01 Ironwood Pharmaceuticals Inc Solid forms of an sgc stimulator
EP3703686A4 (en) * 2017-10-30 2021-11-17 Theracaine LLC HYDROPHOBIC ARENE SULFONATE SALTS
US11186556B1 (en) * 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof
UA119735C2 (uk) 2018-12-20 2019-07-25 Анатолій Семенович Редер Фармацевтична сполука, спосіб її отримання та застосування як лікарського засобу
USD1071069S1 (en) 2019-02-13 2025-04-15 Hs Produkt D.O.O. Stippled textured body for a firearm or the like
USD998740S1 (en) 2019-02-13 2023-09-12 Hs Produkt D.O.O. Firearm
USD994822S1 (en) 2019-02-13 2023-08-08 Hs Produkt D.O.O. Pistol
USD1077123S1 (en) 2019-02-13 2025-05-27 Hs Produkt D.O.O. Firearm sight
USD994821S1 (en) 2019-02-13 2023-08-08 Hs Produkt D.O.O. Pistol
USD1057880S1 (en) 2019-08-09 2025-01-14 Hs Produkt D.O.O. Pistol
JP2024506382A (ja) * 2021-02-15 2024-02-13 プロペラ セラピューティクス インコーポレイテッド アビラテロンプロドラッグ
USD1049292S1 (en) * 2021-04-06 2024-10-29 Springfield, Inc. Pistol
KR20240008356A (ko) * 2021-05-14 2024-01-18 글로벌 블러드 테라퓨틱스, 인크. 헤모글로빈 조정제의 고체 형태
USD1069964S1 (en) 2021-11-03 2025-04-08 Hs Produkt D.O.O. Pistol slide
CN118679157A (zh) * 2021-12-28 2024-09-20 深圳扬厉医药技术有限公司 四氢环庚吲唑化合物的盐型、晶型
USD1057882S1 (en) 2022-08-29 2025-01-14 Springfield, Inc. Combined serrations for a firearm slide
USD1072997S1 (en) 2022-08-29 2025-04-29 Springfield, Inc. Firearm
USD1061781S1 (en) 2022-11-30 2025-02-11 Hs Produkt D.O.O. Pistol
ZAA202301170S (en) 2023-04-28 2024-06-26 Hs Produkt D O O Firearm
WO2025019497A2 (en) * 2023-07-17 2025-01-23 Kura Oncology, Inc. Crystalline forms of a menin inhibitor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234579A (en) * 1977-06-07 1980-11-18 Pfizer Inc. Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
BE881675A (fr) * 1979-02-13 1980-08-12 Leo Pharm Prod Ltd B-lactames derives de l'acide penicillanique leur preparation et leurs utilisations therapeutiques
IE49881B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd B-lactam intermediates
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
GB2084572B (en) * 1980-10-06 1984-07-11 Leo Pharm Prod Ltd 1,1-dioxopenicillanoyloxymethyl 6-(d-aphenylacetamido)penicillanate napsylate
IE51516B1 (en) * 1980-10-06 1987-01-07 Leo Pharm Prod Ltd 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate
IL64009A (en) * 1980-10-31 1984-09-30 Rech Applications Therap Crystalline 1,1-dioxopenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate tosylate hydrates,their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DD209632A5 (de) 1984-05-16
AU1387183A (en) 1983-11-17
US4432987A (en) 1984-02-21
PL241553A1 (en) 1983-11-21
FI831392A0 (fi) 1983-04-22
DK101783D0 (da) 1983-02-28
SU1138030A3 (ru) 1985-01-30
FI76092B (fi) 1988-05-31
JPS58201792A (ja) 1983-11-24
DK101783A (da) 1983-10-24
EP0092968A1 (en) 1983-11-02
SG104087G (en) 1988-07-15
IE54628B1 (en) 1989-12-20
KR840004437A (ko) 1984-10-15
ZA832845B (en) 1984-11-28
EP0092968B1 (en) 1986-03-12
CA1187484A (en) 1985-05-21
HU187068B (en) 1985-11-28
IE830926L (en) 1983-10-23
YU90483A (en) 1986-04-30
EG16412A (en) 1989-03-30
PH18035A (en) 1985-03-06
JPH0119395B2 (cg-RX-API-DMAC7.html) 1989-04-11
YU43170B (en) 1989-04-30
ES8406075A1 (es) 1984-07-01
PT76587B (en) 1986-02-27
DK162168C (da) 1992-03-02
NO156202C (no) 1987-08-19
CS235320B2 (en) 1985-05-15
IL68453A0 (en) 1983-07-31
FI76092C (fi) 1988-09-09
FI831392L (fi) 1983-10-24
IL68453A (en) 1986-08-31
GR78582B (cg-RX-API-DMAC7.html) 1984-09-27
DE3362502D1 (en) 1986-04-17
AU536854B2 (en) 1984-05-24
ES521728A0 (es) 1984-07-01
NO156202B (no) 1987-05-04
PL134978B1 (en) 1985-09-30
NO831430L (no) 1983-10-24
NZ203988A (en) 1986-01-24
DK162168B (da) 1991-09-23
KR860001279B1 (ko) 1986-09-05
PT76587A (en) 1983-05-01

Similar Documents

Publication Publication Date Title
EP0092968B1 (en) Crystalline benzenesulfonate salts of sultamicillin
KR870001982B1 (ko) 결정성 1,1-디옥소페니실라노일옥시 메틸 6-(D-α-아미노-α-페닐아세트아미도)페니실라네이트 토실레이트 수화물의 제조방법.
US3957764A (en) 6-aminopenicillanic acid derivatives
IE49880B1 (en) Penicillin derivatives
IE833045L (en) Crystalline cephem-acid addition salts
RU2051919C1 (ru) Соединения пенема и фармацевтическая композиция на их основе
US4053609A (en) Penicillins and processes for preparing the same
KR0178957B1 (ko) 페넴 화합물
US3822256A (en) Crystalline monohydrates of sodium and potassium cephalexin
SU1015830A3 (ru) Способ получени сложных эфиров 6-амидинопенициллановых кислот или их аддитивных солей с кислотами и его вариант
IE51516B1 (en) 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate
US3997527A (en) Aminomethylarylmethylpenicillin derivatives
US3759898A (en) Synthesis of alpha-(carbo(5-indanyloxy)) benzylpenicillin
US3539562A (en) Alpha - amino - 2,4,6 - cycloheptatrienylmethylcephalosporins
IE53857B1 (en) Antibacterial esters of beta-lactams, and processes and intermediates for their preparation
US3980793A (en) Carbonate esters of penicillins and compositions and methods for treatment of bacterial infections
US3474089A (en) Substituted adamantyl penicillins
US3835115A (en) Alpha-(substituted sulfonamido)arylmethylpenicillins
US3966710A (en) Aminomethylarylmethylpenicillin derivatives
GB2052483A (en) Crystalline cephalosporin salts
US3819600A (en) Alpha-carboxamido acyl derivatives of penicillin
US3542925A (en) 6-amino-penicillanic acid derivatives for control of gram positive bacterial infections
US4009160A (en) Aminomethylarylmethylpenicillin derivatives
KR850000474B1 (ko) 6β-[2-(2'-메틸페녹시카르보닐)-2-티엔-3'-일아세트아미도]페니실란산의 제조방법
US4762827A (en) (5R,6S,8R)-6-(1-hydroxyethyl)-2-(3R-pyrrolidin-2-one-3-yl)thiopenem-3-carboxylic acid

Legal Events

Date Code Title Description
PE Patent expired